ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 142 filers reported holding ARCUS BIOSCIENCES INC in Q2 2020. The put-call ratio across all filers is 0.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,411,534 | +311.0% | 78,637 | +317.7% | 0.04% | +288.9% |
| Q1 2023 | $343,404 | -33.8% | 18,827 | -24.9% | 0.01% | -40.0% |
| Q4 2022 | $518,468 | +149.3% | 25,071 | +206.1% | 0.02% | +66.7% |
| Q2 2022 | $208,000 | +3.0% | 8,190 | +13.9% | 0.01% | -52.6% |
| Q1 2021 | $202,000 | -42.1% | 7,189 | -46.5% | 0.02% | -48.6% |
| Q4 2020 | $349,000 | -61.4% | 13,425 | -74.5% | 0.04% | -36.2% |
| Q3 2020 | $903,000 | +24.4% | 52,676 | +79.5% | 0.06% | +16.0% |
| Q2 2020 | $726,000 | +98.9% | 29,349 | +11.6% | 0.05% | +92.3% |
| Q1 2020 | $365,000 | +78.9% | 26,309 | +60.8% | 0.03% | +85.7% |
| Q1 2019 | $204,000 | – | 16,361 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $50,877,000 | 22.64% |
| Octagon Capital Advisors LP | 2,489,974 | $78,584,000 | 16.99% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $27,451,000 | 8.41% |
| BVF INC/IL | 3,960,948 | $125,008,000 | 5.00% |
| PFM Health Sciences, LP | 3,431,010 | $108,283,000 | 4.05% |
| EcoR1 Capital, LLC | 3,265,101 | $103,047,000 | 3.22% |
| Alphabet Inc. | 2,563,441 | $80,902,000 | 2.62% |
| Boxer Capital, LLC | 1,432,200 | $45,200,000 | 2.32% |
| SECTORAL ASSET MANAGEMENT INC | 338,480 | $10,682,000 | 1.90% |
| PARK CIRCLE Co | 64,000 | $2,020,000 | 1.68% |